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To the Editor,
Drugs that block the renin-angiotensin-aldosterone system,
including converting enzyme inhibitors, angiotensin recep-
tor blockers and, more recently, the direct renin inhibitor
aliskiren are among the most widely prescribed antihyper-
tensive agents [1, 2]. When prescribed in the second half of
pregnancy, these agents can cause a constellation of Wnd-
ings that includes oligohydramnios, pulmonary hypoplasia,
joint contractures, hypocalvaria, fetal growth retardation,
kidney disease, arterial hypotension, and death. We report
on the adverse sequelae noted following maternal self-med-
ication with an angiotensin receptor blocker [3].
A 34-year-old woman aVected by systemic lupus erythe-
matosus on medication with the antimalarial hydroxychlo-
roquine, the -blocker metoprolol, the calcium-channel
blocker nifedipine and the angiotensin receptor blocker
losartan became pregnant. Losartan was stopped and the
dose of the remaining antihypertensive agents adjusted.
In week 34 of gestation, oligohydramnios was noted and
later also fetal growth retardation. In week 37, because of
nonreactive fetal heart rate monitoring, a male newborn
was delivered by caesarean section without neonatal alarm
indicators. Body weight (2.250 kg) and length (0.46 m)
were below the 10th percentile for the gestational age.
However, head circumference (0.330 m), mean blood pres-
sure (from 35 to 45 mmHg) and the clinical examination
were normal. Urinalysis was positive (++) for protein but
circulating creatinine (16 mol/l) and urea (4.1 mmol/l)
were normal. Ultrasound evaluation showed bilateral
hyperechogenic kidneys with normal size [4]. We were ini-
tially unable to ascribe the aforementioned pathological
history and Wndings to any particular cause. Detailed ques-
tioning in retrospect revealed that the mother, unaware of
the toxicity potential, had resumed losartan 50 mg/day in
week 32 of gestation without consulting any physician.
Fetopathy induced by the use of drugs targeting the
renin-angiotensin-aldosterone system has been so far
reported among women who fail to stop the medication
after conception (mostly because they are lost to follow-up)
or, more rarely, among women inadvertently prescribed the
medication during pregnancy [3]. To the best of our knowl-
edge, this might be the Wrst case of fetopathy that results
from self-medication [5].
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